title: Target validation using Phase 0 clinical trials: Promises and pitfalls.
authors.affiliation: Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: Laura S
authors.initials: LS
authors.lastname: Angelo
authors.forename: Razelle
authors.initials: R
authors.lastname: Kurzrock
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational